Key result
Survey finds ~82% of physicians perform routine rhythm monitoring after AF ablation.
Why the study?
Clinical endpoints for pulmonary vein isolation vary significantly, with no consensus on defining AF recurrence or managing post-ablation recurrences.
Cross-Sectional (n=107)
Yes
This multi-national survey highlights significant real-world heterogeneity among electrophysiologists in defining and monitoring clinical success after atrial fibrillation ablation.
Answers are grounded in this paper and cite their sources.
Post-ablation AF monitoring and success definitions vary widely among clinicians; leaves open standardization and outcome effects for prospective study.
Atrial fibrillation (AF) is a major challenge for the healthcare field. Pulmonary vein isolation is the most effective treatment for the maintenance of sinus rhythm. However, clinical endpoints for the procedure vary significantly among studies. There is no consensus on the definition of recurrence and no clear roadmap on how to deal with recurrences after a failed ablation. The purpose of this study was to perform a survey in order to show how clinicians currently approach this knowledge gap. An online survey, supported by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, was conducted between 1 April 2022 and 8 May 2022. An anonymous questionnaire was disseminated via social media and EHRA newsletters, for clinicians to complete. This consisted of 18 multiple-choice questions regarding rhythm monitoring, definitions of a successful ablation, clinical practices after a failed AF ablation, and the continuance of anticoagulation. A total of 107 replies were collected across Europe. Most respondents (82%) perform routine monitoring for AF recurrences after ablation, with 51% of them preferring a long-term monitoring strategy. Cost was reported to have an impact on the choice of monitoring strategy. Self-screening was recommended by most (71%) of the respondents. The combination of absence of symptoms and recorded AF was the definition of success for most (83%) of the respondents. Cessation of anticoagulation after ablation was an option mostly for patients with paroxysmal AF and a low CHA2DS2-VASc score. The majority of physicians perform routine monitoring after AF ablation. For most physicians, the combination of the absence of symptoms and electrocardiographic endpoints defines a successful result after AF ablation.
No takes yet. Share an insight, caveat, or question.
Schwab et al. (2022) conducted a cross-sectional in Atrial fibrillation (physician practices) (n=107). EHRA survey on AF ablation practices was evaluated on Proportion of physicians performing routine monitoring for AF recurrences after ablation. Most respondents perform routine monitoring for AF recurrences after ablation, and 83% define a successful ablation as a combination of absence of symptoms and no recorded AF.
Synapse has enriched 10 related papers. Consider them for comparative context: